Discover our new oral solid dose (OSD) development capabilities at our Bend, Oregon site.
Mastering the complexities of active pharmaceutical ingredient (API) commercial production is crucial for ensuring the consistent quality, efficacy, and safety of innovative pharmaceutical products. It’s also a strategic imperative for successfully launching and maintaining these drug products in the market, as it directly impacts the drug's reliability and consumer trust.
A contract development and manufacturing organization (CDMO) partner's role in this journey is pivotal, offering guidance and solutions that pave the way for commercial success. This webinar explores Thermo Fisher Scientific’s holistic approach to API commercial production, which encompasses scalability, sustainability, cost optimization, and manufacturing flexibility.
Watch our experts discuss strategies for enhancing commercial production processes, whether producing an orphan drug or a mass-market product. Through case studies, they demonstrate the importance of working with a CDMO that has the resources, expertise, and flexibility to advance an API from early process development to commercial readiness.
Key webinar takeaways include:
Watch the on-demand webinar now.